To evaluate whether the amount of vessel-bound MPO contributes to blood pressure regulation in heart failure patients, we performed the above correlation and multivariate analyses by stratifying patients in groups with (n = 9) or without (n = 16) heparin therapy during levosimendan-administration (table 3 and 4). This evidence concerns the gene MPO and heart failure.